Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the earnings per share (EPS) high or low?
The earnings per share (EPS) of -0.28 is 84% above its 5-year average of -1.80, near the high end of its 5-year range (-4.24–-0.01).
85.07% above its 12-month average of -1.88.
Reported quarterly EPS; no daily interpolation. Q3 FY2026 (2026-07-31): 0.47.
EPS growth vs the same fiscal quarter in the prior fiscal year, last 12 comparable quarters.
EARNINGS PER SHARE (EPS)
-0.28
EARNINGS PER SHARE (EPS) AVG TTM
-1.88
EARNINGS PER SHARE (EPS) AVG 3Y
-2.46
EARNINGS PER SHARE (EPS) AVG 5Y
-1.80
EARNINGS PER SHARE (EPS) AVG 10Y
N/A
EARNINGS PER SHARE (EPS) AVG 15Y
N/A
EARNINGS PER SHARE (EPS) AVG 20Y
N/A
CURRENT VS TTM AVG
+85.07%
CURRENT VS 3Y AVG
+88.61%
CURRENT VS 5Y AVG
+84.44%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
enGene Holdings Inc.
Market Cap
$120.92M
Earnings Per Share (EPS)
-0.28
TTM Avg
-1.88
3Y Avg
-2.46
5Y Avg
-1.80
Market Cap
$121.23M
Earnings Per Share (EPS)
-1.22
TTM Avg
-1.33
3Y Avg
-1.36
5Y Avg
-1.18
Market Cap
$120.39M
Earnings Per Share (EPS)
-0.53
TTM Avg
-0.95
3Y Avg
-1.58
5Y Avg
-1.49
Market Cap
$122.13M
Earnings Per Share (EPS)
-1.65
TTM Avg
-6.80
3Y Avg
-14.48
5Y Avg
-27.17
Market Cap
$119.38M
Earnings Per Share (EPS)
-40.87
TTM Avg
-73.79
3Y Avg
-78.14
5Y Avg
-71.60
Market Cap
$119.26M
Earnings Per Share (EPS)
N/A
TTM Avg
-5.70
3Y Avg
-9.83
5Y Avg
-0.70
Market Cap
$119.23M
Earnings Per Share (EPS)
-4.09
TTM Avg
-2.59
3Y Avg
-6.03
5Y Avg
-6.97
Market Cap
$124.90M
Earnings Per Share (EPS)
-13.24
TTM Avg
-14.57
3Y Avg
-14.57
5Y Avg
-81991.29
Market Cap
$125.14M
Earnings Per Share (EPS)
-0.54
TTM Avg
-0.92
3Y Avg
-84.40
5Y Avg
-674.41
| NAME | MARKET CAP | EARNINGS PER SHARE (EPS) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| enGene Holdings Inc. (ENGN) | $120.92M | -0.28 | -1.88 | -2.46 | -1.80 |
| Seer, Inc. (SEER)vs › | $121.23M | -1.22 | -1.33 | -1.36 | -1.18 |
| Tenaya Therapeutics, Inc. (TNYA)vs › | $120.39M | -0.53 | -0.95 | -1.58 | -1.49 |
| Cibus, Inc. (CBUS)vs › | $122.13M | -1.65 | -6.80 | -14.48 | -27.17 |
| Spruce Biosciences, Inc. (SPRB)vs › | $119.38M | -40.87 | -73.79 | -78.14 | -71.60 |
| BGM Group Ltd. (BGM)vs › | $119.26M | N/A | -5.70 | -9.83 | -0.70 |
| LENZ Therapeutics, Inc. (LENZ)vs › | $119.23M | -4.09 | -2.59 | -6.03 | -6.97 |
| Tonix Pharmaceuticals Holding Corp. (TNXP)vs › | $124.90M | -13.24 | -14.57 | -14.57 | -81991.29 |
| TuHURA Biosciences, Inc. (HURA)vs › | $125.14M | -0.54 | -0.92 | -84.40 | -674.41 |
| Coya Therapeutics, Inc. (COYA)vs › | $116.58M | -1.07 | -1.13 | -1.07 | -0.91 |
Trailing EPS (TTM)
$-0.28
Forward EPS (Est.)
$-1.81
P/E Ratio
N/A
Formula: EPS = Net Income / Weighted Average Shares Outstanding
Why EPS matters:
EPS (Earnings Per Share) represents the portion of a company's profit allocated to each outstanding share. Higher EPS indicates greater profitability on a per-share basis.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EARNINGS PER SHARE (EPS) |
|---|---|
| 2025-10-31 | -2.29 |
| 2024-10-31 | -1.46 |
| 2023-10-31 | -4.24 |
| 2022-10-31 | -1.84 |
| 2021-10-31 | -0.01 |
| 2020-10-31 | -0.95 |
